Quantcast

Latest Biologic Stories

2015-01-13 16:25:45

Exclusive Licensing Agreement for CAR T Cell, TCR, NK Cell Programs and Associated Technologies for the Development of Non-Viral Adoptive Cellular Therapies GERMANTOWN, Md., BOSTON,

2015-01-08 23:06:47

Selexis SA announced today the first therapeutic biologic generated with the Selexis SUREtechnology Platform™ has been approved for market. Geneva, Switzerland

2015-01-08 16:27:21

BEIJING, Jan. 8, 2015 /PRNewswire/ -- China Biologic Products, Inc.

2015-01-08 08:28:41

Moderna venture to advance mRNA vaccines and mRNA-based passive immunity therapies CAMBRIDGE, Mass., Jan.

2015-01-07 23:00:46

Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop

2015-01-07 16:24:35

LONDON, Jan. 7, 2015 /PRNewswire/ -- About Psoriasis and Its TypesPsoriasis is a common immune-mediated disease of the skin.

2015-01-06 04:21:32

CAMBRIDGE, England, January 6, 2015 /PRNewswire/ -- Crescendo Biologics, a company focused on the discovery and development of best-in-class Humabody(TM) human VH antibody

2015-01-05 16:25:48

Represents a Novel Approach to Treating B-cell Lymphoma in Dogs KANSAS CITY, Kan., Jan.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.